Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome
- 30 November 2010
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 94 (6), 2385-2388
- https://doi.org/10.1016/j.fertnstert.2010.02.041
Abstract
No abstract availableKeywords
Funding Information
- Medizinische Universität Innsbruck
This publication has 17 references indexed in Scilit:
- The role of the endogenous opioid system in polycystic ovary syndromeFertility and Sterility, 2009
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usageAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistanceGynecological Endocrinology, 2007
- Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic womenFertility and Sterility, 2006
- Early Effects of Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomized, Double-Blind, Placebo-Controlled TrialJournal of Clinical Endocrinology & Metabolism, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003
- Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women*Experimental and Clinical Endocrinology & Diabetes, 1998
- Opiate antagonist treatment of ovarian failureHuman Reproduction, 1993
- AN IMPROVED METHOD FOR THE DETECTION OF HETEROZYGOSITY OF CONGENITAL VIRILIZING ADRENAL HYPERPLASIAClinical Endocrinology, 1980